Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope Share
SHARE YOUR STORY!
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
Menu
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
  • Join PW

Daily Archives: December 1, 2020

  1. Home>
  2. 2020>
  3. December>
  4. 1
New Matter Patent for PR001, a Treatment for Gaucher Disease

New Matter Patent for PR001, a Treatment for Gaucher Disease

  • Post author:Kendall Mason
  • Post published:December 1, 2020
  • Post category:Gaucher Disease/Parkinson's Disease

Prevail Therapeutics, a company that focuses on developing gene therapies for neurodegenerative diseases, has announced that a composition of matter patent has been issued for PR001. This therapy is intended…

Continue Reading New Matter Patent for PR001, a Treatment for Gaucher Disease
A Drug that Extends the Life of Children With Progeria Has Been Approved by the FDA

A Drug that Extends the Life of Children With Progeria Has Been Approved by the FDA

  • Post author:Rose Duesterwald
  • Post published:December 1, 2020
  • Post category:Progeria

An article recently appeared in Health News by NPR describing progeria, an extremely rare disease. There are only twenty people in the United States diagnosed with progeria. The disease causes…

Continue Reading A Drug that Extends the Life of Children With Progeria Has Been Approved by the FDA
Phase 3 RHB-204 Trial Begins for NTM Lung Disease
source: pixabay.com

Phase 3 RHB-204 Trial Begins for NTM Lung Disease

  • Post author:Jessica Lynn
  • Post published:December 1, 2020
  • Post category:Nontuberculous Mycobacteria Lung Disease

On November 20, 2020, biopharmaceutical company RedHill Biopharma Ltd. announced the initiation of a Phase 3 clinical trial to study the orally administered RHB-204. The drug is designed to treat…

Continue Reading Phase 3 RHB-204 Trial Begins for NTM Lung Disease
COVI-DROPS Enter Human Study to Fight Mild Cases of COVID-19

COVI-DROPS Enter Human Study to Fight Mild Cases of COVID-19

  • Post author:Rose Duesterwald
  • Post published:December 1, 2020
  • Post category:COVID-19

Sorreto Therapeutics recently announced through Globe Newswire that it has filed an application for its investigational new drug COVI-DROPS (STI-2099). The study will investigate the safety and efficacy of the…

Continue Reading COVI-DROPS Enter Human Study to Fight Mild Cases of COVID-19
Phase 1 LYT-100 Study Shows Promise for IPF, Lymphedema
PhotoLizM / Pixabay

Phase 1 LYT-100 Study Shows Promise for IPF, Lymphedema

  • Post author:Jessica Lynn
  • Post published:December 1, 2020
  • Post category:COVID-19/Idiopathic Pulmonary Fibrosis

Recently, biotherapeutics company PureTech Health announced that their Phase 1 trial to evaluate LYT-100 (deupirfenidone) has completed. During the multiple ascending dose and food effect study, researchers analyzed the safety,…

Continue Reading Phase 1 LYT-100 Study Shows Promise for IPF, Lymphedema
New DOA Gene Therapy Solution Developed
source: pixabay.com

New DOA Gene Therapy Solution Developed

  • Post author:Jessica Lynn
  • Post published:December 1, 2020
  • Post category:Optic atrophy and cataract- autosomal dominant

Each year, thousands lose their vision to dominant optic atrophy (DOA), an inherited disease that negatively impacts the optic nerves. However, researchers and scientists from Trinity College Dublin may have…

Continue Reading New DOA Gene Therapy Solution Developed
Palliative Care for Idiopathic Pulmonary Fibrosis Patients
Source: Pixabay.com

Palliative Care for Idiopathic Pulmonary Fibrosis Patients

  • Post author:Kendall Mason
  • Post published:December 1, 2020
  • Post category:Idiopathic Pulmonary Fibrosis

There is a stigma that comes with the term "palliative care," as it is typically associated with hospice and terminal illnesses. This is not the case, as palliative care is…

Continue Reading Palliative Care for Idiopathic Pulmonary Fibrosis Patients
Genetic Testing Could Benefit Patients with Pancreatic Cancer
source: pixabay.com

Genetic Testing Could Benefit Patients with Pancreatic Cancer

  • Post author:Jessica Lynn
  • Post published:December 1, 2020
  • Post category:Pancreatic Cancer

When you think about genetic testing, what first comes to mind? Is it pancreatic cancer? While this might not be the first thing you consider, a new study suggests that…

Continue Reading Genetic Testing Could Benefit Patients with Pancreatic Cancer
Ice Bucket Challenge Funds Canadian ALS Guidelines

Ice Bucket Challenge Funds Canadian ALS Guidelines

  • Post author:Jessica Lynn
  • Post published:December 1, 2020
  • Post category:Amyotrophic Lateral Sclerosis

This past month, the Ice Bucket Challenge was brought back into the spotlight when co-founder of the ALS Ice Bucket Challenge, Pat Quinn, unfortunately passed away. As the ALS Association…

Continue Reading Ice Bucket Challenge Funds Canadian ALS Guidelines

Featured


Picture of Family


Metastatic Breast Cancer: Navigating Grief


Picture of Ralph Family walking


Rethinking What It Means to Live With Acromegaly


Illustration of mentor program members


The Let’s Chat CAR T One-on-One Mentor Program: Speaking with Someone Who Understands What You Are Going Through

SHARE YOUR STORY!
We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.
Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Partner With Us
Submit a Story

Keep Up to Date

Subscribe to Our Newsletter
Check Out Rare Events
Get Inspired By Our Memes

Learn More

About Us
Rare Diseases and Conditions
Terms of Use
Privacy Notice
Privacy Policy for CA Residents
EU/UK Privacy Notice
Data Privacy Framework: Consumer Privacy Policy
Consumer Health Data Privacy Policy
Cookie Notice

Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope

© Copyright 2024 Patient Worthy

Sign Up With a Patient Worthy Account and Share Your Rare Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info

We're Happy You're Here!

What best describes you when it comes to rare disease? (check all that apply)

What rare disease(s)/conditions are most important to you?

Visit Home Page or

Thank you for signing up for a Patient Worthy Account!

Have a rare disease story to share? Let us know

Share Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info